ethyl 6-tert-butyl-4-oxo-1,4-dihydroquinoline-3-carboxylate, 97%, 5g

4-(4-Aminophenoxy)-N-methylpicolinamide, 95.0%, 5g

5-Isobutylimidazolidine-2,4-dione, 95.0%, 5g

Dietilamina, min 99,5%, para síntesis, 1L, envase de vidrio

(2-(Azetidin-1-yl)pyrimidin-5-yl)boronic acid, 95.0%, 1g

2,2'-(3-Methylthiophene-2,5-diyl)bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolane), 96%, 5g

3-(1,3-benzodioxol-5-yl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 500mg

(4-chlorophenyl)[2-(methoxymethoxy)phenyl]methanone, 95.0%, 1g

Tetrahydro-2H-pyran-4-yl methanesulfonate, 97.0%, 1g

3-isopropylpiperidine, 95.0%, 1g

3-(2-Methyl-2H-tetrazol-5-yl)-benzenesulfonamide, 95.0%, 500mg

cis-4-Octene>95.0%(GC)1mL

4-(Difluoromethoxy)-2-fluoroaniline, 95.0%, 100mg